Global Travel Vaccines Market Outlook to 2028


DUBLIN, March 22, 2022 /PRNewswire/ — The report “Travel Vaccines Market Forecast to 2028 – Impact of COVID-19 and Regional Analysis by Product and Application” has been added to from offer.

The Travel Vaccines Market is Expected to Reach US$5,914.22 million by 2028 from US$3,078.94 million in 2021; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028.

Travel and tourism have become an integral part of the human way of life. Travel and tourism have not only transformed people’s current routine, but also provided opportunities to explore different cultures, traditions, spiritualisms, rural ethnicities and wellness across the world, and to take health breaks.

For international travel, vaccination is considered a safety and precautionary measure to prevent the spread of infections. Various countries have their own policies to protect their citizens from travel-associated infections. For example, in the United Kingdom, the National Health Service (NHS) organizes vaccination or routine vaccination campaigns for its citizens. If a person is traveling outside the UK they should be vaccinated to protect against infectious diseases such as hepatitis A, typhoid and yellow fever. Likewise, in Saudi Arabia, travelers coming from the Hajj and Umrah pilgrimages are required to present proof of vaccination against meningitis and seasonal flu. Various countries require mandatory evidence of vaccination documented on an International Certificate of Vaccination or Prophylaxis (ICVP).

According to estimates by the World Tourism Organization (WTO), the number of tourist arrivals has increased from 1 billion in 2010 to 1.6 billion in 2020. The UNWTO has estimated that long-distance travel will increase at a rate by 5.4% and travel within the regions will grow by 3.8% per year. In addition, tourist arrivals have increased steadily in areas such as Asia and Europe in 2020. Here is the table illustrating the UNWTO estimates for international tourist arrivals, by region.

The aforementioned estimates suggest that travel and tourism will increase in the coming years. Additionally, conditions such as economic crises and demand for better employment opportunities have contributed significantly to the boom in travel and tourism worldwide. Thus, the increase in travel and tourism activities propels the demand for travel vaccines.

On the basis of product, the global travel vaccines market is segmented into hepatitis A, hepatitis B, meningococcal vaccines and others. The others segment held the largest market share in 2021. However, the meningococcal vaccines segment is expected to register the highest CAGR in the market during the forecast period.

Based on application, the global travel vaccines market is segmented into domestic travel and overseas travel. The outbound travel segment held a larger market share in 2021 and is expected to register a higher CAGR in the market during the forecast period.

WHO, WTO, CDC and Ministry of Health and Family Welfare are some of the primary as well as secondary sources that are referred to during the preparation of the Global Travel Vaccines Market report.

Reasons to buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Travel Vaccines Market.
  • Highlights key business priorities to help companies realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Global Travel Vaccines Market, thereby allowing players across the value chain to develop effective long term strategies.
  • Develop/modify business expansion plans using substantial growth offering in both developed and emerging markets.
  • Dig deep into the global market trends and outlook associated with the factors driving the market, as well as those hindering it.
  • Improve the decision-making process by understanding the strategies that drive security interest in customer products, segmentation, pricing, and distribution.

Main topics covered:

1. Introduction

2. Travel Vaccines Market – Key Takeaways

3. Research methodology

4. Global Travel Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST analysis
4.2.1 North America: PEST analysis
4.2.2 Europe: PEST analysis
4.2.3 Asia Pacific: PEST analysis
4.2.4 Middle East and Africa: PEST analysis
4.2.5 South and central America: PEST analysis
4.3 Expert opinion

5. Travel Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in travel and tourism
5.1.2 Growing incidence of infectious diseases
5.2 Market Constraints
5.2.1 High cost of travel vaccines
5.3 Market Opportunities
5.3.1 Vaccine awareness
5.4 Future trends
5.4.1 Endless demand for vaccines
5.5 Impact analysis

6. Travel Vaccines Market – Global Analysis
6.1 Global Travel Vaccines Revenue Forecast and Analysis
6.2 Global Travel Vaccines Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players

7. Travel Vaccines Market Analysis – By Product
7.1 Overview
7.2 Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
7.3 Hepatitis A
7.3.1 Overview
7.3.2 Hepatitis A: Travel Vaccines Market – Revenue and Forecast to 2028 (USD Million)
7.4 Hepatitis B
7.4.1 Preview
7.4.2 Hepatitis B: Travel Vaccines Market – Revenue and Forecast to 2028 (USD Million)
7.5 Meningococcal vaccines
7.5.1 Overview
7.5.2 Meningococcal Vaccines: Travel Vaccines Market – Revenue and Forecast to 2028 (USD Million)
7.6 Others
7.6.1 Preview
7.6.2 Other: Travel Vaccines Market – Revenue and Forecast to 2028 (USD Million)

8. Travel Vaccines Market Analysis – By Application
8.1 Overview
8.2 Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
8.3 Inner journey
8.3.1 Preview
8.3.2 Domestic Travel: Travel Vaccines Market – Revenue and Forecast to 2028 (USD Million)
8.4 One way trip
8.4.1 Preview
8.4.2 Outbound Travel: Travel Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9. Travel Vaccines Market – Geographical Analysis

10. Impact of the COVID-19 pandemic on the global travel vaccines market
10.1 North America: Assessing the impact of the COVID-19 pandemic
10.2 Europe: Assessing the impact of the COVID-19 pandemic
10.3 Asia Pacific: Assessing the impact of the COVID-19 pandemic
10.4 Middle East and Africa: Assessing the impact of the COVID-19 pandemic
10.5 South and central America: Assessing the impact of the COVID-19 pandemic

11. Travel Vaccines Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in Travel Vaccines Market, (%)
11.3 Organic developments
11.3.1 Overview
11.4 Inorganic developments
11.4.1 Presentation

12. Company Profiles
12.1 GlaxoSmithKline plc.
12.1.1 Key Facts
12.1.2 Description of the activity
12.1.3 Products and services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co., Inc.
12.2.1 Key Facts
12.2.2 Description of the activity
12.2.3 Products and services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Main developments
12.3 Sanofi
12.3.1 Key Facts
12.3.2 Description of the activity
12.3.3 Products and services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Novartis AG
12.4.1 Key Facts
12.4.2 Description of activity
12.4.3 Products and services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer Inc.
12.5.1 Key Facts
12.5.2 Description of activity
12.5.3 Products and services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Dynavax Technologies
12.6.1 Key Facts
12.6.2 Description of activity
12.6.3 Products and services
12.6.4 Financial overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Emergent BioSolutions Inc.
12.7.1 Key Facts
12.7.2 Description of activity
12.7.3 Products and services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Abbott
12.8.1 Key Facts
12.8.2 Description of activity
12.8.3 Products and services
12.8.4 Financial overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9.1 Key Facts
12.9.2 Description of activity
12.9.3 Products and services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Major Developments
12.10 Valneva SE.
12.10.1 Key Facts
12.10.2 Description of activity
12.10.3 Products and services
12.10.4 Financial overview
12.10.5 SWOT Analysis
12.10.6 Key Developments

13. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Woodsenior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

SOURCE Research and Markets


Comments are closed.